Inga Buchmann

Research output

Research Output per year 1985 2000 2001 2003 2006 2007 2008 2009 2015 2021 2021

• 42 Journal articles
• 7 Scientific review articles
• 1 Comments/Debates
• 1 Letters

Research Output per year

Research Output per year

Search results

• 2011

  Therapie des differenzierten Schilddrüsenkarzinoms

  Translated title of the contribution: The treatment of differentiated thyroid cancerHubold, C., Buchmann, I. & Lehnert, H., 04.2011, In: Deutsche Medizinische Wochenschrift. 136, 17, p. 891-5 5 p.

  Research output: Journal Articles › Scientific review articles › Research
• 2009

  Myeloablative radioimmunotherapy in conditioning prior to haematological stem cell transplantation: Closing the gap between benefit and toxicity?

  Buchmann, I., Meyer, R. G., Mier, W. & Haberkorn, U., 01.03.2009, In: European journal of nuclear medicine and molecular imaging. 36, 3, p. 484-498 15 p.

  Research output: Journal Articles › Scientific review articles › Research

  • Radioimmunotherapy 100%
  • Organ 66%
  • Monoclonal Antibody 66%
  • Bone Marrow 66%
  • Patient 40%
  10 Citations (Scopus)
• 2008

  [18F]-FDG-PET in der Diagnostik gastrointestinaler Tumoren

  Translated title of the contribution: [18F]-FDG-PET in the diagnostics of gastrointestinal tumorsBuchmann, I., Ganten, T. M. & Haberkorn, U., 04.2008, In: Zeitschrift fur Gastroenterologie. 46, 4, p. 367-75 9 p.

  Research output: Journal Articles › Scientific review articles › Research

  • Gastrointestinal Tumor 100%
  • Deoxyglucose 100%
  • Patient 33%
  • Neoplasm 33%
  • Relapse 22%

• Myeloablative radioimmuntherapien zur konditionierung bei patienten mit AML, MDS und multiplem myelom vor stammzelltransplantation

  Translated title of the contribution: Myeloablative radioimmunotherapies in the conditioning of patients with AML, MDS and multiple myeloma prior to stem cell transplantationBuchmann, I., 01.08.2008, In: Tumor Diagnostik und Therapie. 29, 4, p. 195-207 13 p.

  Research output: Journal Articles › Scientific review articles › Research

  • Patient 100%
  • Syndrome 100%
  • Acute Myeloid Leukemia 100%
  • Radioimmunotherapy 100%
  • Multiple Myeloma 100%
• 2007

  Radiolabeled peptides and proteins in cancer therapy

  Wängler, C., Buchmann, I., Eisenhut, M., Haberkorn, U. & Mier, W., 2007, In: Protein and Peptide Letters. 14, 3, p. 273-9 7 p.

  Research output: Journal Articles › Scientific review articles › Research

  • Tositumomab I 131 100%
  • Ibritumomab Tiuxetan 50%
• 2005

  Radioimmunotherapy for treatment of acute myeloid leukaemia and myelodysplastic syndrome: Conceptual chances

  Buchmann, I., Meyer, R. G., Herr, W., Helisch, A. & Bartenstein, P., 06.2005, In: NuklearMedizin. 44, 3, p. 107-117+N21-N22

  Research output: Journal Articles › Scientific review articles › Research

  • Acute Myeloid Leukemia 100%
  • Radioimmunotherapy 100%
  • Myelodysplastic Syndrome 100%
  • Patient 40%
  • Complication 40%
  5 Citations (Scopus)
• 2001

  Novel imaging techniques in NHL: clinical results with PET imaging

  Buchmann, I. & Reske, S. N., 2001, In: Annals of Hematology. 80 Suppl 3, p. B54-7

  Research output: Journal Articles › Scientific review articles › Research